---
$id: https://graph.org.ai/products/commodity/51343813
$type: Product
source: UNSPSC
code: "51343813"
title: "Efavirenz and lamivudine/zidovudine"
class: "51343800"
classTitle: "Combination antivirals"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Efavirenz and lamivudine/zidovudine

**UNSPSC Code**: 51343813
**Class**: [Combination antivirals](Combination antivirals.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug for treatment of HIV.  This is for copackaged product. The first component, EFAVIRENZ, has US FDA Unique Ingredient Identifier of JE6H2O27P8. The second component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The third component, ZIDOVUDINE, has US FDA Unique Ingredient Identifier of 4B9XT59T7S.

